Save the date ! A dialogue on cell based interceptive medicine

Europe needs a new approach to medicine fuelled by powerful technologies that will help people remain healthy throughout their lifetime. Not only do we have to change the way diseases are detected and treated, we also need to prepare for emerging health challenges. Digital and biomedical technologies have the capacity to potentiate other breakthroughs and transform medicine. Their integration promises to provide high-quality healthcare, strengthen Europe’s research and health industry, innovation capacity and global leadership. What are the steps that should be prioritised at a European level to boost this potential? Our high-level guests from politics, science, industry and the clinics will share their vision with you.
08 déc
A dialogue on cell based interceptive medicine
Lieu : Online
Organisateur : LifeTime intiative
Intervenants : Geneviève Almouzni, Institut Curie, France, Christine Chomienne, Mission Board Cancer at the European Commission, France, Angelika Eggert, Charité, Berlin, Stefan Oelrich, Bayeur Pharmaceuticals, Germany, Nikolaus Rajewsky, MDC, Germany, Aviv Regv, Human Cell Atlas, Genentech, US, Manfred Weber, European Parliament, Germany


16:30 Opening
Introduction - Today’s medical challenges, a perspective from oncology
• Angelika Eggert, Director of the pediatric oncology and hematology department at the Charité-Universitätsmedizin Berlin

LifeTime vision – Improving healthcare through cell-based interceptive medicine
• Geneviève Almouzni, LifeTime coordinator, Institut Curie, CNRS

Panel discussion - A lifetime impact: how to unleash the innovation potential of biomedical technologies?
• Christine Chomienne, Vice-Chair of the Mission Board Cancer at the European Commission
• Anna Lönnroth Sjödén, Head of Unit – Healthy Lives, People Directorate Directorate-General for

Research and Innovation, European Commission
• Stefan Oelrich, Member of the Board of Management of Bayer AG, President Pharmaceuticals
• Aviv Regev, Co-chair Human Cell Atlas, Head of Genentech Research & Early Development
• Manfred Weber, Member of the European Parliament

Closing remarks – Next steps towards solutions for Europe
• Nikolaus Rajewsky, LifeTime coordinator, Max Delbrück Center for Molecular Medicine in the
Helmholtz Association

18:00 End

Moderator: Maryline Fiaschi, Managing Director Science|Business

Read more on LifeTime initiative